Pneumagen Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.pneumagen.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model
- First Posted Date
- 2022-08-19
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Pneumagen Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT05507567
- Locations
- 🇬🇧
hVIVO Services Limited, London, United Kingdom
Safety and Tolerability of Single and Multiple Doses of Neumifil
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Pneumagen Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05093530
- Locations
- 🇬🇧
Hammersmith Medicines Research (HMR), London, United Kingdom
News
No news found